So, Tivozanib is a inhibitor that focuses on the VEGFR, which is a vascular endothelial growth factor receptor. It’s mostly used to treat RCC. It does this by stopping angiogenesis, which is how tumors get their blood supply.
There are two types of Tivozanib – 890 micrograms and 1.34 milligrams in capsules. The usual dose is 1.34 mg taken every day for 21 days. Then you take a break for 7 days.
That whole cycle is 28 days long. You can take Tivozanib with or without food. It comes in bottles with 21 capsules.
Tivozanib is super important for treating RCC. It goes after the root of the problem and could help patients do a lot better.
